About David Hallett

>20 years in the Pharma, CRO and pharmatech sectors as a medicinal chemist and executive manager. Significant experience across Discovery and early Development of small molecules. Therapeutic area expertise within Neuroscience & pain, application of iPSCs in drug discovery and protein degradation therapeutic modalities.

Educated at Cambridge University and the University of Manchester (PhD) followed by post-doctoral research at The University of Texas (Austin).